In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
Equillium, Inc. (NASDAQ:EQ), a biotechnology company with a market capitalization of $25.15 million and current stock price of $0.71, announced today the positive outcomes of their Phase 2 clinical ...
The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are excited to host the annual Crohn’s & Colitis Congress®, taking place Feb. 6-8, in San Francisco, CA. This ...
A groundbreaking test can now predict colorectal cancer risk in IBD patients with over 90 accuracy offering a less invasive ...
A doctor and medical advisor has shared the top five factors that could increase people's risk at getting colorectal cancer, and what to do to prevent it as 54% of bowel cancer cases are preventable ...
Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...
Colorectal cancer is becoming a significant public health issue in India, especially among individuals under 50 years old.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback